Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:1715-1717
Published online before print May 17, 2007, doi: 10.1161/STROKEAHA.107.487165
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/6/1715    most recent
STROKEAHA.107.487165v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, R. A.
Related Collections
Right arrow Other hypertension
Right arrowRelated Article

(Stroke. 2007;38:1715.)
© 2007 American Heart Association, Inc.


Editorials

Hypertension and Cerebral Blood Flow

Implications for the Development of Vascular Cognitive Impairment in the Elderly

Ronald A. Cohen, PhD

From the Department of Psychiatry and Human Behavior, Brown University, The Miriam Hospital, Coro Bldg, 3-West, One Hoppin St, Providence, RI.

Correspondence to Ronald A. Cohen, Department of Psychiatry and Human Behavior, Brown University, The Miriam Hospital, Coro Bldg, 3-West, One Hoppin St, Providence, RI. E-mail rcohen@lifespan.org


Key Words: cerebral blood flow • hypertension • vascular cognitive impairment


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The contribution of cerebrovascular disease to development of dementia in the elderly remains a perplexing and unresolved issue with direct clinical implications. In the early part of the past century, the popular notion was that some type of vascular pathology (eg, "hardening of the arteries") was a contributing factor. Yet, the idea that cerebrovascular disease plays a significant role in Alzheimer disease (AD) and related degenerative brain disorders was dismissed by a majority of dementia researchers, because AD pathology was found to be strongly related to specific neuronal abnormalities involving β-amyloid, {tau} protein, and disruption of cholinergic brain systems.1,2 Yet, clinical and experimental research conducted over the past several years suggests that cerebrovascular disease may play a greater role in degenerative dementia than was previously believed.3–8 Vascular disease is associated with increased risk for AD.3,9–11 Also, many of the biochemical processes involved in AD share common mechanisms with cerebrovascular disease factors12,13 (endothelial health, oxidative stress response, insulin metabolism, etc), suggesting possible convergence of underlying neuropathological mechanisms, at least among certain patients.14 There is a compelling need for studies aimed at achieving greater understanding about the relationship between vascular disease and the development of dementia in the elderly.

The diagnostic classification of vascular dementia (VaD) was developed to account for cases in which severe functional impairments could be unambiguously attributed to stroke or other well-defined vascular pathology.15 Unfortunately, the diagnosis of VaD is a clinical conundrum, because pure cases are more the exception than the rule, and also many of the cognitive . . . [Full Text of this Article]


Related Article:

Longitudinal Changes in Cerebral Blood Flow in the Older Hypertensive Brain
Lori L. Beason-Held, Abhay Moghekar, Alan B. Zonderman, Michael A. Kraut, and Susan M. Resnick
Stroke 2007 38: 1766-1773. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Gerontol A Biol Sci Med SciHome page
I. Hajjar, F. Yang, F. Sorond, R. N. Jones, W. Milberg, L. A. Cupples, and L. A. Lipsitz
A Novel Aging Phenotype of Slow Gait, Impaired Executive Function, and Depressive Symptoms: Relationship to Blood Pressure and Other Cardiovascular Risks
J Gerontol A Biol Sci Med Sci, September 1, 2009; 64A(9): 994 - 1001.
[Abstract] [Full Text] [PDF]